Wenjie Xu
About Wenjie Xu
Wenjie Xu is the Senior Director of Clinical Biomarkers and CDx Development at BeiGene, with extensive experience in precision medicine, translational medicine, and regulated diagnostics.
Company
Wenjie Xu currently serves as the Senior Director of Clinical Biomarkers and CDx Development at BeiGene, a renowned biotechnology company. At BeiGene, Xu oversees the precision medicine strategy, supporting global clinical development, drug and diagnostic approval, and marketing efforts. BeiGene is at the forefront of innovative cancer treatments, and Xu's role is pivotal in driving the research and development efforts forward.
Title
Wenjie Xu holds the position of Senior Director, Clinical Biomarkers and CDx Development at BeiGene. Her responsibilities include leading precision medicine strategies to support global clinical development and ensure the successful approval and marketing of drugs and diagnostics. Xu's expertise lies in her ability to manage regulatory interactions and life cycle management across multiple therapeutic areas.
Education and Expertise
Wenjie Xu has a comprehensive educational background with a focus on biological sciences and molecular genetics. She earned her PhD in ICMBS from Columbia University, an MS in Molecular Genetics from Miami University, and a BS in Biological Sciences and Technologies from Zhejiang University. Xu's expertise includes translational medicine, regulated diagnostics, biomarker, and companion diagnostic development. She possesses extensive knowledge of the drug discovery processes and has significant experience in regulatory interactions.
Career Background
Wenjie Xu has held several notable positions throughout her career. Before joining BeiGene, she worked at AstraZeneca as the Global Precision Medicine Lead, Oncology, from 2020 to 2022. Prior to that, she was the Principal Scientist in Translational Sciences at NanoString Technologies, Inc. for five years. Xu's early career includes positions as a Senior Research Scientist at Carnegie Mellon University and a Senior Research Fellow at Sanford Burnham Prebys Medical Discovery Institute. These roles have equipped her with a strong foundation in precision medicine and translational research.